The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.
Also called NCT06224296
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Registry
-
NCT06224296
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06224296. Allocation not applicable; no masking; primary purpose prevention. Start 2024-03-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults
- Condition
- Sub-healthy
- Condition
- Hyperlipidemia
- Condition
- Toxic Metal Ions Accumulation
- Intervention (Device)
- DFPP
- Intervention (Device)
- DFPP
- Intervention (Device)
- DFPP
- Lead sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Collaborator
- Shanghai Mengchao Cancer Hospital
Record details
- Record id
cardio:ct-nct06224296- Content hash
3d77120f6b95519534e0223b25ba9bdaf8a7f6fbbbd7d2007947027553f731cf